Screening men for prostate cancer cut mortality rates by about half in a large study, researchers report. The screening test under investigation is called a prostate-specific antigen (PSA) test, which measures blood levels of a protein produced by prostate gland cells and is a marker for prostate cancer.

Read More

MESOSELIOMA MESOMARK BLOOD TEST The Food and Drug Administration (FDA) approved the MESOMARK assay to help monitor response to treatment in malignant mesothelioma patients. The MESOMARK test signifies the beginning of a new era in monitoring mesothelioma malignancies,” said Dr. W. Jeffrey Allard, vice president and chief scientific officer of Fujirebio Diagnostics. “As the first […]

Read More